Are you scheduled for or planning to have a biopsy done at UNC Health? For this trial, we are looking for people who are 18 years or older who are suspected or diagnosed with Stage IV/metastatic cancer, including: • Lung: Non-small cell lung cancer (NSCLC), • Head and Neck: Squamous Cell Carcinoma (HSNCC), excluding nasopharyngeal and salivary gland cancer; • Kidney: Clear Cell Renal Cell Carcinoma (ccRCC); • Bladder: Urothelial Carcinoma (UC); Skin: Cutaneous Melanoma, excluding Uveal Melanoma.

We are doing this study to test a behavioral lifestyle program designed specifically for adolescent and young adult cancer survivors. Study participants will use a smartphone app and Fitbit activity tracker to help them develop healthier habits.

Have you been diagnosed with triple negative breast cancer and have residual disease after receiving preoperative therapy and surgery?

Do you have stage III colon cancer? Have you already completed surgery? If so, you may qualify for a study that uses a blood test called ctDNA to determine your treatment and to monitor for recurrence.

Do you have metastatic renal cell carcinoma? If so, you may be able to take part in a research study collecting information about how your therapy is affecting your quality of life.

Have you been diagnosed with Liver cancer. If so, you may be able to take part in a research study looking to to measure the efficacy and safety of durvalumab IV solution plus bevacizumab IV solution after transarterial radioembolization(Y90 glass microsphere TARE) in participants with unresectable HCC amenable to locoregional therapy

The purpose of this study is to evaluate an investigational ultrasound technique called acoustic angiography to improve physicians' ability to assess cancer risk.

Do you have advanced or metastatic non small cell lung cancer, squamous cell carcinoma of the head and neck, colorectal cancer, or renal cell carcionma? Have you tried previous therapies that did not work? If so, you may be able to take part in this study. Investigational study drug is provided.

This is a study for people with early-stage inoperable lung cancer. We want to find out if adding a drug called atezolizumab to stereotactic body radiation therapy (SBRT) is more effective than SBRT alone for this type of cancer.

Do you have triple negative breast cancer? Have you had surgery following chemotherapy? You may be able to participate in a study to find out if stopping pembrolizumab infusions after surgery is just as effective at reducing your risk of cancer recurrence.